<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> incidence and <z:hpo ids='HP_0011420'>deaths</z:hpo> are reduced by the detection and removal of early-stage, treatable <z:hpo ids='HP_0002664'>neoplasia</z:hpo> but we lack proven biomarkers sensitive for both <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and pre-invasive <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The aims of this study were to determine if <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> exhibit characteristic patterns of biomarker expression and to explore whether a tissue-discovered (and validated) biomarker is differentially expressed in the plasma of patients with colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Candidate <z:chebi fb="40" ids="33697">RNA</z:chebi> biomarkers were identified by oligonucleotide microarray analysis of colorectal specimens (222 <z:mpath ids='MPATH_458'>normal</z:mpath>, 29 <z:mpath ids='MPATH_270'>adenoma</z:mpath>, 161 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and 50 <z:hpo ids='HP_0002583'>colitis</z:hpo>) and validated in a previously untested cohort of 68 colorectal specimens using a custom-designed oligonucleotide microarray </plain></SENT>
<SENT sid="3" pm="."><plain>One validated biomarker, KIAA1199, was assayed using qRT-PCR on plasma extracted <z:chebi fb="40" ids="33697">RNA</z:chebi> from 20 colonoscopy-confirmed healthy controls, 20 patients with <z:mpath ids='MPATH_270'>adenoma</z:mpath>, and 20 with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Genome-wide analysis uncovered reproducible gene expression signatures for both <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> compared to controls </plain></SENT>
<SENT sid="5" pm="."><plain>386/489 (79%) of the <z:mpath ids='MPATH_270'>adenoma</z:mpath> and 439/529 (83%) of the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> biomarkers were validated in independent tissues </plain></SENT>
<SENT sid="6" pm="."><plain>We also identified genes differentially expressed in <z:mpath ids='MPATH_270'>adenomas</z:mpath> compared to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>KIAA1199 was selected for further analysis based on consistent up-regulation in <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, previous studies and its interest as an uncharacterized gene </plain></SENT>
<SENT sid="8" pm="."><plain>Plasma KIAA1199 <z:chebi fb="40" ids="33697">RNA</z:chebi> levels were significantly higher in patients with either <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> or <z:mpath ids='MPATH_270'>adenoma</z:mpath> (31/40) compared to <z:hpo ids='HP_0002664'>neoplasia</z:hpo>-free controls (6/20) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Colorectal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> exhibits characteristic patterns of gene expression </plain></SENT>
<SENT sid="10" pm="."><plain>KIAA1199 is differentially expressed in neoplastic tissues and KIAA1199 transcripts are more abundant in the plasma of patients with either <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> or <z:mpath ids='MPATH_270'>adenoma</z:mpath> compared to controls </plain></SENT>
</text></document>